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Background. Human rhinoviruses (HRVs) are the most prevalent human pathogens, and consist of 101 serotypes that are
classified into groups A and B according to sequence variations. HRV infections cause a wide spectrum of clinical outcomes
ranging from asymptomatic infection to severe lower respiratory symptoms. Defining the role of specific strains in various HRV
illnesses has been difficult because traditional serology, which requires viral culture and neutralization tests using 101
serotype-specific antisera, is insensitive and laborious. Methods and Findings. To directly type HRVs in nasal secretions of
infants with frequent respiratory illnesses, we developed a sensitive molecular typing assay based on phylogenetic
comparisons of a 260-bp variable sequence in the 5’ noncoding region with homologous sequences of the 101 known
serotypes. Nasal samples from 26 infants were first tested with a multiplex PCR assay for respiratory viruses, and HRV was the
most common virus found (108 of 181 samples). Typing was completed for 101 samples and 103 HRVs were identified.
Surprisingly, 54 (52.4%) HRVs did not match any of the known serotypes and had 12–35% nucleotide divergence from the
nearest reference HRVs. Of these novel viruses, 9 strains (17 HRVs) segregated from HRVA, HRVB and human enterovirus into
a distinct genetic group (‘‘C’’). None of these new strains could be cultured in traditional cell lines. Conclusions. By molecular
analysis, over 50% of HRV detected in sick infants were previously unrecognized strains, including 9 strains that may represent
a new HRV group. These findings indicate that the number of HRV strains is considerably larger than the 101 serotypes
identified with traditional diagnostic techniques, and provide evidence of a new HRV group.
Citation: Lee W-M, Kiesner C, Pappas T, Lee I, Grindle K, et al (2007) A Diverse Group of Previously Unrecognized Human Rhinoviruses Are Common
Causes of Respiratory Illnesses in Infants. PLoS ONE 2(10): e966. doi:10.1371/journal.pone.0000966
INTRODUCTION
Human rhinoviruses (HRVs), members of picornavirus family, are
small nonenveloped viruses with a 7200-base mRNA positive sense
RNA genome [1]. The first HRV was discovered in 1956 [2,3],
and by 1987, 101 serotypes (1A and 1B to 100) were identified
using susceptible cell cultures and specific antisera [4,5,6].
Multiple epidemiologic studies of serotype circulation conducted
between 1975–1983 showed that .90% of field isolates could be
identified with the 90 serotype-specific antisera prepared before
1973, and many serotypes identified earlier were still circulating
[6,7,8]. These results suggested HRV serotypes are stable and do
not undergo influenza virus-like antigenic drift [7].
HRVs are the most prevalent human respiratory pathogens
[8,9,10,11,12]. Annually, HRVs are responsible for .50% of all
acute upper respiratory illness (common colds), the most frequent
human illness. HRV infections occur year round worldwide and
are epidemic in early fall and late spring in the temperate regions.
HRV infections cause a wide range of clinical outcomes including
asymptomatic infections,[13,14,15,16,17] upper respiratory ill-
nesses, and in children, asthmatics, and other susceptible
populations, lower respiratory symptoms.[18,19,20,21,22,23].
Defining the role of specific strains in various HRV illnesses has
been difficult because traditional serology requires the isolation of
HRV in susceptible cell cultures and neutralization tests against all
101 serotype-specific antisera [6]. This traditional serological
method is insensitive, labor intensive and cumbersome [24]. More
sensitive and faster molecular methods have been developed for
serotyping enteroviruses, which are closely related to HRV [25]. In
addition, molecular typing methods have been used to identify the
links between illnesses and specific strains of pathogens such as
dengue viruses, influenza viruses, human papillomaviruses, hepatitis
C viruses, and HIV [26,27]. Molecular typing involves PCR
amplification of a portion of the target viral genome, sequencing and
phylogenetic analyses. In this report, we analyzed clinical specimens
from sick infants with a new molecular method, and identified 26
new HRV strains including 9 that constitute a new HRV group.
RESULTS
Sequence variability of P1-P2 region between 101
HRV serotypes
The length of the P1-P2 sequences (region between primer sites P1
and P2 in Figure 1) varied only slightly between the 101
established serotypes, ranging from 261 to 273 bases. The
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serotypes in this region was 45% (Figure 2). This result was similar
to the maximum pairwise divergence of 101 VP4 sequences (46%)
and slightly lower than that of VP1 sequences (54%) [28,29].
Furthermore, 97.5% of all the serotype pairs had .9% pairwise
nucleotide divergence. The maximum pairwise divergences (%) of
P1-P2 sequences among HRVA and HRVB viruses were 33% and
27%, respectively. These results demonstrated the potential utility
of this region for differentiating HRV serotypes.
P1-P2 sequences of 101 HRV serotypes clustered
into 2 previously defined genetic groups: HRVA and
HRVB
Phylogenetic tree reconstruction confirmed that the 101 P1-P2
sequences clustered into 2 genetic groups, A and B, (Figure 3). The
P1-P2 phylogenetic distribution of the serotypes into group was
identical to that of published trees based on VP1 and VP4-VP2
sequences [28,29,30], with the same 76 serotypes in the HRVA
group and 25 serotypes in HRVB group (Figure 3). The topology
of the P1-P2 tree was similar to that of the VP1 and VP4-VP2
trees [28,29,30]. These results agreed with previous reports that
the nucleotide phylogenies of HRVs are consistent across the
whole genome, from 5’NCR through polyprotein to 3’NCR [31].
Accurate typing of 79 clinical isolates by
phylogenetic tree reconstruction of P1-P2
sequences
To test whether P1-P2 sequences were suitable for HRV serotype
identification, we compared the typing results of 79 culturable
clinical isolates obtained by P1-P2 sequences with those by NIm-
1A sequences of VP1. The degenerate primers EV292 and EV222
for PCR amplification of NIm-1A region were not sensitive
enough for direct detection of small amount of HRV in original
clinical samples (data not shown), and high titer infected cell
lysates of cultured isolates were needed to produce enough PCR
product for cloning and sequencing. The length of NIm-1A and
P1-P2 sequences ranged 329–356 bases and 263–271 bases,
respectively. Based on phylogenetic tree reconstruction of NIm-1A
sequences, the 79 clinical isolates were assigned to 24 different
serotypes with highly significant bootstrap values (77–100%,
Table 1). Identical assignment results were obtained with P1-P2
tree, although a number of assignments (HRV1B, HRV15,
HRV85 and one of the 5 HRV89) had low but still significant
bootstrap values (60%, 64%, 61% and 62%, respectively).
Interestingly, the nucleotide divergence between the clinical
isolates and the respective reference strain was lower at the P1-
P2 region (mean 3.5%, range 0–8%) than at the NIm-1A region
(mean 9.6%, range 5–13%) (Table 1). This result agreed with
previous reports that nucleotide sequences were more conserved at
the NCRs than the coding region due to the preservation of
conserved RNA structure elements within the NCR[31,32].
HRV detection in clinical specimens
Nasal lavage samples of 181 illnesses from 26 infants with frequent
respiratory illnesses were analyzed by Respiratory Multicode
Assay [33]. HRV was detected in 108 samples (60%) (Table 2).
Other viruses detected were enterovirus, RSV, adenovirus,
coronavirus, influenza A virus, metapneumovirus and parain-
fluenza virus. Among the 108 HRV-positive samples, 80 had only
HRV and 28 had coinfection with at least one other respiratory
virus.
The identity of HRV in 101 of the 108 samples was determined
by molecular typing. Of the 7 samples that were not typed, 2 had
no sample left and 5 did not yield P1-P2 fragments by semi-nested
PCR. A total of 103 HRVs were identified in 101 samples. Only 2
samples contained 2 different HRVs, indicating a low rate of
infection with more than one strain. Of the 103 HRVs, serotypes
were assigned to 49 HRVs by phylogenetic tree reconstruction
(Table 3). The assignments of 45 HRVs were strongly supported
by highly significant bootstrap values (.74%). One assignment
(HRV20) had a low but still significant bootstrap value (52%). The
P1-P2 sequences of these 46 HRVs had 94–100% identity with the
respective reference serotypes. Three sequences clustered with
HRV89 but had poor bootstrap values (,50%) although they had
99% identity with HRV89 reference sequences. This was probably
because these 3 HRVs also matched well with HRV36, which has
97% identity with HRV89 in the P1–P2 region. These 46 HRVs
Figure 1. Schematic representation of the first 1100 base of a HRV
genome showing the locations of the highly conserved regions (P1, P2
and P3) and variable region between P1 and P2 (P1-P2 in red) at the
5’NCR and the PCR fragments used in this study. P1, P2 and P3 are
located at bases 163–181, 443–463 and 535–551, respectively in HRV16
genome. PCR fragment A (about 900bps) was used to determine the
5’NCR sequences ofall 101 HRVserotypes. Itwas amplified usingpan-HRV
PCR forward primer P1-1, which anneals to conserved region P1, and
a serotype-specific reverse primer annealed to the 5’ end of VP2 gene
(between base# 1000 and 1100). PCR fragment B (about 390 bps) was
generated with pan-HRV PCR forward primer P1-1 and reverse primer P3-
1. PCR fragment C (about 300 bps) was generated with forward primer
P1-1 andanequimolarmixtureofreverse primersP2-1, P2-2andP2-3. The
variable sequences of P1-P2 were used for the molecular typing assay.
doi:10.1371/journal.pone.0000966.g001
Figure 2. Distribution of pairwise nucleotide divergence values
between 101 HRV serotypes. The horizontal axis shows the value of
divergence (%) in pairwise comparisons and the column height
indicates the frequency of observations. Divergence values were
calculated as distance value6100%.
doi:10.1371/journal.pone.0000966.g002
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PLoS ONE | www.plosone.org 2 October 2007 | Issue 10 | e966were grouped into 23 HRV serotypes; 42 (19 serotypes) were
HRVA and 4 (4 serotypes) were HRVB viruses (Table 3).
Identification of new HRV strains
The P1-P2 sequences of 54 HRVs did not cluster with the
homologous sequences of any of the 101 serotypes in phylogenetic
tree reconstructions (Figure 4). These 54 HRVs clustered into 26
new unique strains with high degree of nucleotide divergence from
the respective nearest reference serotypes (mean 24.6%, range 12–
35%) and between strains (mean 32.5%, range 10–46%) (Table 4).
Different new HRVs of the same strain had a high degree of
identity among themselves (mean 98.4%, range 94–100%,
Table 4). Seventeen of the new strains clustered with group A
HRV (Figure 4) and had 12–35% pairwise nucleotide divergence
from the nearest reference serotype (Table 4). Among them, 5
Figure 3. Phylogenetic tree depicting the relationships among all 101 HRV serotypes in the P1-P2 region of 5’NCR. This tree was constructed
using the neighbor joining method according to the distances (divergences) between all pairs of sequences in a multiple alignment. The confidence
of sequence clustering was evaluated by bootstrapping (1000 replicates). Only significant bootstrap values (.500) were shown. The scale bar (top
left) represents the genetic distance (nucleotide substitutions per site). The 101 HRV serotypes (R) clustered into 2 previously defined groups: HRVA
and HRVB with a perfect bootstrap value (1000). HRVA group had 76 serotypes and HRVB, 25 serotypes.
doi:10.1371/journal.pone.0000966.g003
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PLoS ONE | www.plosone.org 3 October 2007 | Issue 10 | e966strains (W7, W15, W24, W28 and W36) clustered in a distant
branch near serotypes 12, 45 and 78; 7 strains (W6, W10, W11,
W12, W17, W23 and W25) in distant branch near serotypes 51, 65
and 71; strains W8, W9, W20 and W38 formed a new branch, and
strain W33 was the lone member of a new branch. Moreover, 9
strains (W1, W13, W18, W21, W26, W31, W32, W35 and W37)
separated from both HRVA and HRVB (Figure 4) and had 31–
35% pairwise divergence from the nearest reference serotype
(Table 4). We propose that they represent a new HRV genetic
group (HRVC). None of the new strains clustered with HRVB
viruses.
Interestingly, none of the samples containing the new
HRV strains produced CPE in standard WI-38 or MRC-5 cell
cultures used for the detection and isolation of HRV (data not
shown).
HRVC was distinct from human enterovirus (HEV)
HEVs are closely related to HRVs [1], and comprise .65 distinct
serotypes that include polioviruses, coxsackieviruses A and B,
echoviruses and the newer numbered EVs. HEVs are classified
into 5 groups: poliovirus and human enterovirus A-D (HEV-A-D),
according to both biological and molecular properties. Like
HRVs, some HEVs are upper respiratory pathogens. To de-
termine the relationship of HRVC to HEVs, phylogenetic tree
reconstruction was performed with the P1-P2 sequences of 9
HRVC strains and respective sequences of all known HEV
(n=74). The results indicate that HRVC viruses are distinct from
HEV: the pairwise divergence of P1-P2 sequences between
a HRVC strain and the respective nearest HEV ranged from
31% to 35% (Figure 5).
Table 1. Identification of culturable HRV clinical isolates by phylogenetic tree reconstruction.
..................................................................................................................................................
Serotype # Isolates NIm1A Region of VP1 P1-P2 Region of 5’NCR
Boot-strap Value (%)
Identity to Reference
sequence (%) Boot-strap Value (%)
Identity to Reference
sequence (%)
HRV1B 1 86 90 60 97
HRV9 1 90 91 83 96
HRV11 1 100 91 99 98
HRV15 1 100 90 64 96
HRV18 1 100 94 90 96
HRV19 11 100 89–91 98–100 95–96
HRV21 2 100 92 93–98 97–98
HRV28 3 99–100 87–89 99–100 97
HRV34 3 95–100 90 100 95
HRV36 1 90 91 75 97
HRV38 7 100 90 98–100 92–98
HRV43 5 100 88 100 97
HRV47 5 99–100 90–91 87–91 97
HRV49 4 82–94 90 84 96–97
HRV54 4 93–95 90–91 85–95 98–99
HRV55 3 100 95 100 97
HRV56 9 96–99 88–89 81–94 93–95
HRV57 1 100 95 100 98
HRV60 1 100 90 99 95
HRV61 1 100 93 99 95
HRV65 1 100 94 100 99
HRV85 2 100 90–92 61 95
HRV89
a 5 77–80 91–92 62–96 99–100
HRV98 6 80–98 91–95 95–100 97–98
a)Four isolates clustered with P1-P2 reference sequence with highly significant bootstrap values (96%), and one with lower but still significant bootstrap value (62%).
doi:10.1371/journal.pone.0000966.t001
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Table 2. Viruses detected in nasal samples of 26 infants with
frequent respiratory illnesses by Respiratory Multicode Assay.
......................................................................
Viruses No. of positive samples
HRV 108
Enterovirus 4
RSV A and B 24
Adenovirus 16
Coronavirus (OC43 and NL63) 15
Influenza A 14
Metapneumovirus 14
Parainfluenza 12
None 22
Multiple viruses
a 41
a)34 and 7 samples had 2 and 3 viruses, respectively.
doi:10.1371/journal.pone.0000966.t002
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In this report we demonstrate that the pool of circulating HRV
strains is significantly larger than the collection of 101 known
serotypes. Less than half of the HRV detected in these young
infants corresponded to previously recognized serotypes (Table 3),
and 54 are previously unrecognized HRVs belonging to 26 new
strains (Table 4). Moreover, 9 of the strains form a new genetic
group "C" that is distinct from the previously defined groups
HRVA and HRVB and the human enteroviruses (Figure 5). The
remaining 17 new strains cluster into existing distant or new
branches in HRVA group (Figure 4). Interestingly, none of the
new viruses grew in standard tissue culture, which may explain
why these viruses were previously undetected.
These new HRV strains were detected with a sensitive
molecular method to type HRV directly from the original clinical
specimens. This new assay had 3 key components: sensitive pan-
HRV primers and semi-nested PCR to amplify P1-P2 region from
cDNA prepared from original clinical specimens, a sequence
database of 260-bp P1-P2 region of 5’NCR of all 101 HRV
serotypes to serve as standard references for HRV identification,
and phylogenetic tree reconstruction of the new P1-P2 sequences
and the 101 homologous reference sequences. Phylogenetic tree
reconstruction has been shown to be more accurate than the other
sequence analysis methods for molecular typing of enteroviruses
[34]. Interestingly, the 5’NCR is not suitable for typing of
enterovirus. For example, the 5’NCR sequence of coxackieviruses
do not correlate with serotype and VP1 sequence due to frequent
recombination at the 5’NCR [35,36]. In contrast, HRV maintains
consistent phylogeny across its genome and has limited re-
combination [31], and this characteristic enables 5’NCR sequence
(P1-P2) to be used for strain identification. For enteroviruses, VP1
sequencing is commonly used for molecular serotyping because
this region contains major antigenic sites that correlate well with
serotype [25]. However, VP1 sequences of HRV are less
conserved, and degenerate primer pairs such as EV292 and
EV222 [24] that target this region were relatively insensitive for
PCR amplification.
The 101 established HRV serotypes (HRV1A to HRV100)
were discovered and designated between 1956 and 1987. They
were isolated using susceptible WI-38 cell cultures and then
defined with serotype-specific antisera [4,5,6]. Multiple epidemi-
ologic studies of serotype circulation conducted between 1975–
1983 showed that .90% of the field isolates could be identified
with the 90 serotype-specific antisera (HRV1A through HRV89)
prepared before 1973 and many serotypes identified earlier were
still circulating [8,11] [6,7]. These results suggested that almost all
HRV serotypes had already been identified and new serotypes
were not evolving [6,7]. In fact, only one possible new serotype,
HRV-Hanks, was reported in the next 20 years (1987 to 2006),
and it was subsequently shown to be HRV21 by careful sequence
analysis and neutralization testing [30].
Recently, studies utilizing molecular techniques instead of
culture-based diagnostics have provided evidence of additional
strains of HRV [37,38]. For example, Lamson and colleagues
identified 8 new HRVs in New York State (NY) by VP4
sequencing. They concluded that these HRVs represented a new
genetic clade because they clustered in a branch at the root of the
HRVA phylogenetic tree [37]. In addition, McErlean and
colleagues obtained the complete genome sequence of a new
HRV strain, HRV-QPM, in Queensland, Australia. They showed
by phylogenetic analysis that HRV-QPM was a new member of
HRVA and belonged to a new genetic sub-lineage of HRVA,
HRV-A2, and the 8 new NY HRVs also belonged to HRV-A2
[38].
To compare the identities of these newly reported HRVs with
our new strains, we performed phylogenetic tree reconstruction
using P1-P2 sequences of our new strains, HRV-QPM, and the
101 established serotypes; and then a similar analysis using VP4
sequences of HRV-QPM, 8 NY HRVs, and the 101 established
serotypes. The P1-P2 phylogenetic tree (not shown) revealed that
HRV-QPM and one of our new HRVA viruses, W24, were the
same strain and thus supported McErlean’s conclusion that HRV-
QPM was a group A virus. The VP4 tree (not shown) confirmed
McErlean’s finding that HRV-QPM and the 8 NY HRVs
belonged to the same cluster within HRVA group. Therefore
the 8 NY HRVs and HRV-QPM were related to our 17 new
HRVA strains. In contrast, our 9 HRVC strains form a distinct
group separated from both HRVA and HRVB (Figure 4).
Analysis of 5’NCR of all HRV serotypes reveals that there are
both highly conserved sequences (e.g. P1, P2 and P3 primer sites,
Figure 1) and also variable sequences between P1 and P2. The
Table 3. Detection of known HRV serotypes in clinical specimens.
..................................................................................................................................................
Serotype
a # Detected
Boot-strap
Value (%)
Identity to Reference
Sequence (%) Serotype
a # Detected
Boot-strap
Value (%)
Identity to Reference
Sequence (%)
HRV7 2 99–100 96–97 HRV63 1 96 98
HRV12 5 100 97–98 HRV78 6 100 95–99
HRV15 1 74 96 HRV80 1 100 98
HRV19 4 100 95–96 HRV82 1 100 98
HRV20 1 52 95 HRV89
b 5 76–91 99–100
HRV28 3 100 97 HRV98 1 100 98
HRV33 2 100 94 HRV100 1 98 97
HRV38 1 93 95
HRV47 1 78 97 HRV14 1 100 98
HRV49 3 85–92 97 HRV27 1 91 97
HRV54 1 96 99 HRV52 1 89 96
HRV61 2 93 95 HRV83 1 99 98
a)The first 19 serotypes are HRVA. HRV14, 27, 52 and 83, are HRVB.
b)Three additional HRVs clustered with HRV89 reference sequence with insignificant bootstrap values (42–50%).
doi:10.1371/journal.pone.0000966.t003
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PLoS ONE | www.plosone.org 5 October 2007 | Issue 10 | e966260-bp P1-P2 region had up to 45% pairwise nucleotide
divergence between serotypes, similar to that of VP4 (46%) and
VP1 (54%). Moreover, 97.5% of all the P1-P2 pairs from distinct
serotypes had .9% pairwise nucleotide divergence. Despite this
inter-serotype variability, the P1-P2 sequence of 5’NCR was
significantly more conserved between clinical isolates and the
corresponding reference prototype strain (mean divergence 3.5%)
compared to the NIm-1A coding sequences of VP1 (mean
divergence 9.6%, Table 1). These data suggest that 5’NCR
sequences may be under greater selective constraint, and it is
known that this region contains RNA structure elements that are
critical for viral replication and translation [32].
In summary, more than half (52%) of the HRVs detected in
these young infants were new HRV strains, and many of them
clustered into a distinct genetic group C. These findings indicate
that the number of HRV strains has been markedly under-
estimated by traditional viral culture and serotyping techniques,
and also raise additional questions. First, how widespread are these
Figure 4. Phylogenetic tree depicting the relationships among 101 HRV serotypes (R) and 26 new strains (W) in the P1-P2 region of 5’NCR. This
tree was generated as described in Figure 3. None of the new strains clustered with HRVB viruses. Seventeen new strains (blue) belonged to HRVA
group, and 9 strains (red) cluster into a new group (‘‘C’’) that is separate from groups A and B.
doi:10.1371/journal.pone.0000966.g004
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PLoS ONE | www.plosone.org 6 October 2007 | Issue 10 | e966putative ‘‘group C’’ HRV? Our study population consisted of
a group of infants who experienced frequent illnesses, and
additional studies are needed to define the spectrum of HRV
infections in unselected populations, and in subjects of other age
groups. Secondly, is the biology of these novel strains similar to
that of other HRV? The inability to culture these viruses suggests
that receptor utilization or other growth requirements are distinct.
The development of molecular assays for the detection and
analysis of respiratory viruses provide important tools for new
epidemiologic and mechanistic studies to address these questions.
A more complete understanding of the spectrum of respiratory
viruses and their biology is essential for efforts directed at
prevention and treatment of these common and clinically
significant illnesses.
MATERIALS AND METHODS
This study was approved by the Human Subject Committee of the
School of Medicine and Public Health, University of Wisconsin -
Madison. Written informed consent was obtained from the
parents.
HRV samples and clinical specimens
For determining the standard reference sequences, infected cell
lysates of prototype strains of 101 HRV serotypes were obtained
from Dr. Fred Hayden of U. Virginia, Charlottesville (serotype
1A, 1B, 2 to 10, 12 to 89, 91 to100 and Hanks) and ATCC
(HRV11 and HRV90). HRV87 was excluded from the reference
database because it has been reclassified as a human enterovirus
[39,40].
Clinical samples were obtained from two sources. First, samples
were obtained from infants ages 0–1 year participating in
a prospective birth cohort study (Childhood Origins of Asthma)
in Wisconsin to determine the role of viral and host factors in the
pathogenesis of asthma [41]. Of the 285 children who completed
the first year of the study, 27 infants had frequent ($5) moderate
to severe respiratory illnesses, and samples from 26 were available
for further study. Nasal lavage specimens were collected from 181
illnesses between spring of 1999 and spring of 2001. Second, for
validation of our molecular typing assay, infected cell lysates of 79
additional HRV clinical isolates were obtained from Wisconsin
State Laboratory of Hygiene (WSLH). These clinical isolates were
recovered from nasal lavages of infants in 1999 and 2000 using
WI38 cell culture and identified by the characteristic cytopathic
effect and acid lability of HRV [42].
Sequence analysis
Pairwise sequence alignment, multiple sequence alignment, %
identity calculation, distance (divergence) calculation, phylogenetic
tree reconstruction and bootstrap analysis were performed using
software Clustal61.8.3 [43,44]. In a typical analysis, the input
sequences were first processed to produce a multiple alignment
and matrixes of identity and distances (divergence) between all
sequence pairs. The distance matrix was used by the neighbor
joining method to produce an unrooted phylogenetic tree with
branch length proportional to the divergence of the sequences.
The confidence of the clustering of sequences was evaluated by
bootstrapping (1000 replicates). Bootstrap values of .700 (70%)
indicate the highly significant clustering, whereas values ,500
(50%) indicate that the clustering is not statistically significant. The
phylogenetic tree with bootstrap values was visualized using
software NJplot.
Preparation of cDNA from nasal specimens
cDNA preparation was performed as described elsewhere [33].
Briefly, nasal fluid (350 ml) was mixed with extraction carriers
(glycogen and glycoblue) and 750 ml of Trizol LS (Invitrogen
10296), vortexed for 10 minutes, supplied with 230 mlo f
chloroform, vortexed again for 5 minutes and then microfuged
for 5 minutes. The supernatant aqueous phase (,700 ml) was
mixed with 600 ml isopropanol and this mixture was incubated at
room temperature for 1 hr. The RNA precipitant was pelleted by
microfugation for 10 minutes, washed once with 75% ethanol, air-
dried and then dissolved in 20 ml water. To make cDNA, 16 mlo f
RNA solution was mixed with 24 ml of reaction solution contain-
ing Promega AMV-reverse transcriptase, AMV-RT buffer,
random primers, RNAsin and dNTPs and then incubated at
25uC for 5 minutes, 42uC for 10 minutes, 50uC for 20 minutes,
and 85uC for 5 minutes.
Table 4. Detection of novel HRV strains in clinical specimens.
..................................................................................................................................................
New HRV
Strain # Detected
Divergence from the
Nearest Refererence.
Sequence (%)
Identity Among HRVs
of the Same Strain (%)
New HRV
Strain # Detected
Divergence from the
Nearest Refererence.
Sequence (%)
Identity Among HRVs
of the Same Strain (%)
W1 5 32–33 97–100 W21 1 33
W6 3 15 95–100 W23 4 20–21 99–100
W7 2 18–20 97 W24 3 18–19 95–99
W8 1 27 W25 1 23
W9 2 23–24 100 W26 3 34–35 97–100
W10 2 22 98 W28 4 12–13 99–100
W11 1 17 W31 1 35
W12 3 18 97–100 W32 2 31 99
W13 1 31 W33 1 24
W15 1 13 W35 1 33
W17 1 21 W36 1 18
W18 2 32 100 W37 1 35
W20 3 25–26 98–100 W38 3 35 94–99
doi:10.1371/journal.pone.0000966.t004
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in clinical specimens by Respiratory Multicode Assay
(RMA)
RMA is a new high-throughput, multiplex PCR-microsphere flow
cytometry assay system for comprehensive detection of common
respiratory viruses including rhinoviruses (HRV), enteroviruses,
respiratory syncytial viruses (RSV), parainfluenza viruses, in-
fluenza viruses, metapneumoviruses, adenoviruses and corona-
viruses. Details of the RMA assay have been previously described
[33]. The output signal is expressed as MFI (median fluorescence
intensity), and samples with an average signal .6 standard
Figure 5. Phylogenetic tree depicting the relationships between 9 HRVC strains (W in red) and all known HEV (n=74) in the P1-P2 region of
5’NCR. HEV include polioviruses (PV), coxsackieviruses A (CA), coxsackieviruses B (CB), echoviruses (E) and the newer numbered EVs. For 5
serotypes (CA16, CA24, CB4, CB5 and EV71), 2 different P1-P2 sequences were found in GenBank. This tree was generated as described in Figure 3.
HRVC and HEV clustered into 2 different groups.
doi:10.1371/journal.pone.0000966.g005
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PLoS ONE | www.plosone.org 8 October 2007 | Issue 10 | e966deviations of average negative control signals (typically 400 to
500 MFI) are regarded as positive. The RMA is capable of
distinguishing closely related HRV and enteroviruses [33].
Development and validation of the molecular
typing assay
Selection of the target region To identify a genomic region
suitable for molecular typing of HRV, we analyzed all published
HRV sequences. These included complete genome sequences of
8 serotypes (1B, 2, 9, 14, 16,39, 85 and 89) [45,46,47,48,
49,50,51,52] and the Picornavirus Home Page [http://www.iah.
bbsrc.ac.uk/virus/Picornaviridae/],VP1 and VP4-VP2 sequences
of all serotypes [28,29,30], 3D (RNA polymerase) sequences of 48
serotypes [53] and partial 5’NCR sequences of 37 serotypes
[54,55,56]. Careful alignment analysis of these sequences showed
that only the 5’NCR region had highly conserved sequences (P1,
P2 and P3 regions, Figure 1) that could be used for making pan-
HRV primers, and a long variable sequence (P1-P2, Figure 1)
suitable for serotype differentiation. However, 5’NCR sequences
were available for only a fraction of 101 serotypes.
Cloning and sequencing of the 5’NCR of 101 reference
HRV serotypes To establish a reference sequence database for
molecular typing, we cloned and sequenced the 5’NCR of all 101
HRV serotypes. Detailed viral RNA preparation, RT-PCR,
cloning and sequencing procedure have been described else-
where [33]. Briefly, total nucleic acids were prepared from 100 ml
of infected cell lysate by phenol extraction and ethanol precipita-
tion. RT (reverse transcription)-PCR was performed in a RT-PCR
mix (Invitrogen 11922-028) using the following conditions: 30 min
at 50uC, 2 min at 94uC, 33 cycles of (30 sec at 94uC, 30 sec at
50uC, 60 sec at 68uC) and 5 min at 68uC. The PCR primer pairs
were forward primer P1-1 (CAAGCACTTCTGTYWCCCC) for
all serotypes and a serotype-specific reverse primer. Primer P1-1
was designed within the conserved P1 region (Figure 1). The
reverse primer was selected for each of the 101 serotypes within
a region corresponding to bases 1000-1100 of HRV16 near the 5’
end of VP2 gene (Figure 1) according to published sequences [29].
The PCR product, a DNA fragment of about 900 bp covering
75% of the 5’NCR, complete VP4 gene and about 200 bases of
VP2 gene (PCR fragment A of Figure 1), was isolated by agarose
gel electrophoresis. After the agarose was removed by phenol
extraction, PCR fragments were treated with kinase, ligated to
a StuI-linearized plamsid vector pMJ3, and then transformed into
E. coli. Three plasmids with PCR fragment inserted were isolated
for each serotype, amplified and purified. Each viral DNA frag-
ment was completely sequenced (Automated DNA Sequencing
Facility, U. Wisconsin). The serotype identity of each sequence
was verified by matching of its VP4/VP2 sequence to the
respective published sequence [29].
Semi-nested PCR amplification of P1-P2 region from
original clinical specimens Primer P1-1, which amplified the
5’NCR of all 101 serotypes, was chosen as the forward primer. For
reverse primers, multiple candidates were designed within highly
conserved P2 and P3 regions (Figure 1). Primers P3-1 (ACGG-
ACACCCAAAGTAG), P2-1 (TTAGCCACATTCAGGGGC),
P2-2 (TTAGCCACATTCAGGAGCC) and P2-3 (TTAGCC-
GCATTCAGGGG) were selected based on efficient HRV
sequence amplification.
For the first PCR, 2.5 ml of leftover cDNA from the RMA assay
was added to a tube containing 23 ml Platinum PCR SuperMix
HF (Invitrogen 12532-016), 1 ml of forward primer P1-1 (25 mM)
and 1 ml of reverse primer P3-1 (25 mM). The reaction started
with 2 min at 94uC, followed by a ’touchdown’ cycle (The steps
were 94uC for 20 s, 68uC down to 52uC( 2 uC intervals) for 30 s,
and then 68uC for 40 s. There were two cycles for each annealing
temperature down to 54uC followed by 12 cycles at 52uC, and
then a final 5 min at 68uC. This reaction produces a PCR product
of 390 bp (Figure 1, fragment B). For the second PCR, 5 ml of the
first PCR product was transferred to a new PCR tube containing
50 ml Platinum PCR SuperMix HF, 1 ml of forward primer P1-1
(25 mM) and 1 ml of each reverse primer P2-1 (25 mM), P2-2
(25 mM) and P2-3 (25 mM). The reaction conditions are 2 min at
94uC, 28 cycles of (20 sec at 94uC, 30 sec at 52uC, 40 sec at 68uC)
and 3 min at 68uC. The final product is a 300 bp DNA fragment
(Figure 1, fragment C). This semi-nested PCR protocol requires
only 10 copies of cDNA template per sample to produce sufficient
product for cloning and does not produce nonspecific product
from original clinical specimens (data not shown). Fragment C was
then purified, cloned, and 3 plasmids containing fragment C were
isolated and sequenced for each sample. For 2 samples, 2 different
P1-P2 sequences were found, indicating the presence of more than
one serotype/strain, so 6 additional plasmids were analyzed.
Sequencing of the VP1 and 5’NCR of 79 HRV clinical
isolates To determine whether the P1-P2 variable sequences
within the 5’NCR were suitable for the differentiation and
identification of HRV, we compared the typing results by P1-P2
sequences with those of NIm-1A sequences of VP1. NIm-1A is
a dominant antigenic site of HRV first identified for HRV14 [1],
and the homologous sequences of this region correlate well with
serotype of HRVs and enteroviruses [57,58]. Viral RNA was
isolated from virus-infected culture supernatant of 79 HRV
clinical isolates with QIAamp viral RNA mini kit (Qiagen
52904) as described [24]. To obtain the VP1 sequences, viral
RNA was first amplified using primer pair EV292 and EV222 as
described [24] with modified RT-PCR conditions: 10 min at
38uC, 40 min at 50uC, 3 min at 95uC, 40 cycles of (30 sec at
95uC, 45 sec at 42uC, 30 sec at 65uC) and 1 min at 70uC. The
PCR product (,350 bp) was isolated by agarose gel electro-
phoresis and then sequenced [24]. To obtain the 5’NCR
sequences, viral RNA was amplified by RT-PCR using P1-1 and
P3-1 primers, cloned and sequenced.
Assignment of serotypes and new strain A phylogenetic
tree with bootstrap values and a matrix of % pairwise nucleotide
divergence (distance6100%) were generated for each new sequence
(NIm-1A or P1-P2) and 101 homologous reference sequences using
Clustal6with default alignment parameters, which were selected
after testing a range of parameters. Next, a new isolate or detection
was assigned the serotype to which it clustered with in the
phylogenetic tree with a significant bootstrap value (.50%) [34].
In contrast, if the P1-P2 sequence of a new isolate or detection did
notclusterwithoneofthe101serotypesinthephylogenetictree,and
had .9% pairwise nucleotide divergence from the nearest reference
serotype, it was designated as a new strain (prefixed with W). The
threshold pairwise divergence value (9%) for assigning a new strain
was determined after considering the pairwise divergence values
between the 101 known serotypes (Figure 2), and the pairwise
divergence values between reference serotypes and clinical isolates of
the same serotype (Table 1, last column).
Two types of errors could be made in evaluating two sequences:
A) deciding they were the same when they were actually different,
and B) deciding they were different when they were actually the
same. The probability of these errors was determined empirically
using the data shown in Figure 2 and Table 1, respectively.
According to Figure 2, 99%, 98%, 97%, 95%, and 90% of the
P1-P2 pairs of all 101 serotypes had .7%, .8%, .9%, .10%
and .12% pairwise nucleotide divergence, respectively. As shown
in Table 1 (last column), the pairwise nucleotide divergence of all
Novel Rhinovirus Group, Strain
PLoS ONE | www.plosone.org 9 October 2007 | Issue 10 | e966P1-P2 pairs between clinical isolates and the respective reference
serotypes was consistently #8%. Therefore, a threshold of 9% is
associated with probabilities of ,3% and ,1% for errors A and B,
respectively.
Nucelotide sequence accession numbers
The original P1-P2 sequences described in this report have been
deposited in the GenBank sequence database under accession no.
EU126663 to EU126789.
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